Navigation Links
Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
Date:4/26/2013

EAST HANOVER, N.J., April 26, 2013 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) disputes the allegations made by the US Attorney's Office (USAO) for the Southern District of New York (SDNY) in two complaints filed this week and will defend itself in these litigations. 

"We disagree with the way the government is characterizing our conduct in both of these matters and we stand behind our Compliance program," said Andre Wyss , President, Novartis Pharmaceuticals Corporation and President, Novartis Corporation . "NPC invests significant time and resources to help ensure we conduct our business in an ethical and responsible manner. We are committed to doing it right."

The first suit pertains to a previously disclosed investigation into discounts and rebates to specialty pharmacies for Myfortic®. Discounts and rebates by pharmaceutical companies are a customary, appropriate and legal practice as recognized by the Government itself. NPC believes this suit is a significant expansion of the Anti-Kickback Statute that is inconsistent with law and policy in this area, and threatens to undermine pharmaceutical company discounting practices that benefit both consumers and payers, including the Government. 

The second suit is related to a previously disclosed investigation into speaker programs conducted by NPC for the products Lotrel®, Starlix®and Valturna®. NPC believes the Government's wide-ranging allegations that its speaker programs lacked any legitimate business purpose are without merit. Physician speaker programs are promotional programs designed to inform physicians about the appropriate use of medicines and NPC has numerous controls in place to help ensure they are conducted in a compliant fashion. These progr
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
2. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
6. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
7. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
8. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
9. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
10. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
11. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
(Date:11/26/2014)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... investor conferences.  , 31 st NASDAQ Investor ... 2, 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. ... will provide an overview of the company and a business and ... Conference in New York, NY on Tuesday, ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... Oct. 20 Novartis announced today that Tasigna® ... in the first head-to-head comparison with the company,s ... faster and deeper responses than Gleevec when given ... diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) ...
... Two medications commonly used to treat high blood pressure ... heart disease known as stable ischemic heart disease, according to ... Healthcare Research and Quality. A version of the analysis ... Annals of Internal Medicine . , Treatment featuring the ...
Cached Medicine Technology:Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 2Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 3Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 4Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 5Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 6Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 7Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 8Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 9Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 10Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 11Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 12Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 13Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 14Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients 15High Blood Pressure Medicines Show Promise For Treating Heart Disease 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 3
(Date:11/27/2014)... NC (PRWEB) November 27, 2014 ... 12 years in the Charlotte area providing audits, ... examination services to businesses of varying size across ... business owners to meet all of their accounting ... certification through the QuickBooks ProAdvisor Program. When asking ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VogueQueen.com is ... items for ladies across the world. As the premier ... accessories, VogueQueen.com is proud to release a huge selection ... high quality outfits, it is also providing many beautiful ... VogueQueen prom gowns at discounted prices. , “VogueQueen.com ...
(Date:11/27/2014)... Dr. Ronald Receveur, who has a leading Southern Indiana ... tips before patients dig into the annual Thanksgiving feast. ... affordable cosmetic dentistry, and his staff understand that Thanksgiving ... the staff wishes everyone a happy and safe holiday, the ... enjoy a feast that is also healthy on their teeth: ...
(Date:11/27/2014)... Allowing children to help with chores while ... give children responsibility, ownership, boosts self-esteem, and above all, helps ... the real question is, how do you encourage your children ... a study published by Child Development Journal, there is. The ... on a child’s willingness to lend a hand. , ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
Breaking Medicine News(10 mins):Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2
... that smoke from cooking fuel is one of major reasons ... of the WHO feel that an investment in curbing smoke ... over. ,The organization is of the opinion that ... solid fuels, and many a times breathing in smoke equivalent ...
... considered as a beneficial and healthy activity. With the emphasis ... that there’s nothing like a bit of gardening to rev ... Wellness Institute at Northwestern Memorial Hospital in Chicago says that ... get when you bend down at your knees. "It's going ...
... promising results about a three-stage brain surgery, performed on ... by intractable seizures. ,Sadly, none of the ... stimulation, a special diet —could quell the electrical storms ... genetic disease called tuberous sclerosis, the seizures began when ...
... success with a vaccine believed to protect against chancroid, ... it could put an end to this devastating disease ... result in a 10-fold reduction in transmission of HIV ... ,HIV plagues more than 25 million people in sub-Saharan ...
... sun lotions may actually lull the consumer into a ... be the case//. The European commission has got its ... in the labeling of sun lotions and its allied ... offered misleading cues by captivatingly labeling a total protection ...
... of Europe’s biggest Poultry farms, has been in the news, ... bird flu on three of its farms. // Three farms ... and have ensured its safe disposal, cleansing and disinfection procedures. ... statement., ,A restricted zone extending nearly 1 km around ...
Cached Medicine News:Health News:Burn Away Calories In Your Garden 2Health News:Intractable Seizures Can Be Handled By A Three-Stage Brain Operation, Neurosurgeon 2Health News:Intractable Seizures Can Be Handled By A Three-Stage Brain Operation, Neurosurgeon 3Health News:Chancroid Vaccine Holds Promise In Reducing HIV Transmission 2Health News:Chancroid Vaccine Holds Promise In Reducing HIV Transmission 3
... 4.2 Image Processing Video Camera is our ... exclusive ACMI Image Processing (IP) technology, the ... and detail. Exciting new features, enhanced image ... 4.2 an exceptional value. All IP 4.2 ...
... of high-powered Xenon, Metal Halide and ... in a durable, lightweight design. In ... light guide cables, providing optimal brightness ... design., Powerful illumination and simple design ...
... to its design, this is the ... stone therapy in urinary and biliary ... a multipurpose lithotripter with other applications ... nephrolithotomy. ,The basic system comprises the ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: